drugset / Trial / NCT01367886

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

NCT01367886

NaSingle-groupOpen-label

Summary

This study is being done to evaluate the use of a new technology (urine proteomics) - the study of proteins in the urine to identify urine markers of overactive bladder (OAB) from a simple voided urine specimen.

Timeline

Start
2010-08
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fesoterodine Other / unclassified 4 mg Oral

Indications